Fresh Tracks Therapeutics, Inc. (FRTX)
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in September 2009 and is headquartered in Boulder, CO.
Address
2000 CENTRAL AVENUE
BOULDER, CO 80301
Founded
2009
Number of Employees
4
Website
http://www.frtx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)